Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of the HIV Protease Inhibitor Nelfinavir in Patients With Recurrent Symptomatic Adenoid Cystic Cancers of the Head and Neck

NCT01065844 is registered in ClinicalTrials.gov with University of Iowa as lead sponsor.

NCT NCT01065844
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01065844 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of the HIV Protease Inhibitor Nelfinavir in Patients With Recurrent Symptomatic Adenoid Cystic Cancers of the Head and Neck
Lead sponsor
University of Iowa
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2009
Completion date
November 30, 2017
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, adenoid cystic, head and neck neoplasms